First Results from the ADRRAD Trial – Combination Androgen Deprivation Therapy (ADT), Whole Pelvis Radiotherapy (WPRT) and Radium 223 in Recently Diagnosed Metastatic Hormone Sensitive Prostate Cancer (MHSPCa). Issue 3 (March 2018) - Turner, P.G.; Jain, S.; Mitchell, D.M.; Hounsell, A.; Biggart, S.; O'Sullivan, J.M.